FDA Halts Hidden Database
KHN investigation revealed millions of reports of harmful devices
As President Donald Trump called the nation “in good shape” to handle COVID-19, a cache of emails released by officials in Washington state show that top public health authorities feared gear shortages and doctor safety in the early epicenter of sickness and deaths.
Because of a little-known federal exemption program, death data about heart devices sits in inaccessible FDA files that can take up to two years for the public to see under open-records laws.
In our ongoing, crowdsourced investigation with NPR and CBS, we’ve armed future health system pilgrims with the tools they need to avoid exorbitant medical bills and fight back against unfair charges. Here’s a look back at 2019’s stories.
The Texas Medical Board bowed out of the rule-making process for a new law protecting consumers from surprise medical bills. Advocates hailed the new rules written by the state insurance regulators.
A letter from the Senate Finance Committee chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and prices.
Patients at VCU Health will no longer be taken to court and can more easily get financial assistance to pay their bills.
KHN reported this week that the University of Virginia Health System has filed 36,000 lawsuits against patients the past six years.
A Kaiser Health News investigation, which first appeared in The Washington Post, showed that the University of Virginia Health System has sued patients 36,000 times for more than $106 million.
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”
KHN filed multiple Freedom of Information Act requests over months, and the FDA responded Wednesday saying the data about device malfunctions is now publicly available online.
In an interview, FDA Commissioner Scott Gottlieb reacts to a KHN/Fortune investigation of the drawbacks and risks of electronic health records.
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.